Portfolio

  • All
  • Active
  • Exited
 
Accumetrics
Accumetrics is a developer and manufacturer of point of care diagnostics in the cardiovascular and neurovascular disease areas.

Acquired by ITC Nexus in 2013.
AcroMetrix
AcroMetrix is a leading developer and manufacturer of controls and standards for molecular diagnostic tests.

Acquired by Life Technologies in 2010.
Agena Bioscience
Agena Bioscience is a life sciences and clinical diagnostics company that offers the MassARRAY® System for nucleic acid detection.
Akoya Biosciences
Akoya Biosciences enables high-parameter, deep proteomic profiling of tissues.
Althea Technologies
Althea Technologies is a provider of contract manufacturing and services to the pharmaceutical and biotechnology industry.

Acquired by Ajinomoto in 2013.
AltheaDx
AltheaDx is a commercial stage molecular diagnostics company specializing in the field of pharmacogenetics.
Ambion
Ambion is a leader in RNA-based life science research products for handling, preserving, isolating, detecting and measuring RNA.

Acquired by Applied Biosystems Group in 2006.
AngioScore
AngioScore develops, makes and sells leading edge tools for endovascular therapy.

Acquired by The Spectranetics Corporation in 2014.
Applied Precision
Applied Precision is a leading provider of imaging, measurement and analysis systems for the life sciences industry and OEM markets.

Acquired by GE in 2011.
Argonaut Manufacturing Services
Argonaut provides reagent and consumable contract manufacturing services for Molecular Diagnostic and Life Science companies.
Asuragen
Asuragen leverages RNA expertise to focus on emerging opportunities in personalized medicine for cancer patients, creating novel diagnostic products that facilitate early diagnosis and treatment outcome.
Aurora Biotechnologies
Aurora Discovery develops and markets premium high-density microplates for high-throughput screening, live cell imaging and other applications.

Acquired by NEXUS Biosystems in 2009.
Carterra
Carterra develops high throughput analytical instruments for the printing and reading of protein binding arrays.
Confirma
Confirma is a pioneer and leader in application-specific computer-aided-detection for MRI.

Acquired by Merge Healthcare in 2009.
Dharmacon
Dharmacon is the global leader in synthetic RNA and related technologies.

Acquired by Fisher Scientific in 2004.
Dynex
Dynex is a leading designer and manufacturer of automated ELISA microplate workstations, laboratory instruments, consumables and accessories.
Emerging Therapy Solutions
ETS provides analytical software tools and outsourced services to insurance providers and other payers to manage expensive cell and gene therapies.
Estech
Estech develops medical devices that enable less invasive cardiac surgery including coronary artery bypass grafts, valve repair and cardiac tissue ablation.

Acquired by AtriCure, Inc. in 2014.
Freedom Innovations
Freedom Innovations develops, manufactures and markets premium, advanced technology prosthetic devices for lower limb amputees.

Acquired by Health Evolution Partners in 2012.
Interface
Interface specializes in catheter production machines, complex medical balloon development and contract balloon manufacturing.

Acquired by NDC in 2015.
InvisAlert Solutions
InvisAlert Solutions develops software and hardware based technology solutions to improve patient safety in behavioral healthcare settings.
Kinetikos Medical
Kinetikos Medical develops products for small bone surgery including advanced joint replacement implants and fixation and surgical devices.

Acquired by Integra Life Sciences in 2006.
LDR
LDR develops and markets innovative fusion and non-fusion spinal implants to surgeons and patients.

Initial public offering in 2013 (NASDAQ:LDRH). Acquired by Zimmer Biomet in 2016.
Magstim
Magstim is a pioneer in neural stimulation and intraoperative nerve monitoring. The company’s trans-cranial magnetic stimulation device has FDA approval for treatment of major depressive disorder.
Medpricer
MedPricer provides a tech-enabled sourcing service for hospitals to bring the benefits of real-time competition to contracting, resulting in significant cost savings and dramatically reduced negotiation periods.

Acquired by Premier, Inc. in 2019
NEXUS Biosystems
NEXUS Biosystems provides automation systems for sample storage and management to pharma/biotech and academic research institutions.

Acquired by Brooks Automation in 2011.
Nimble Therapeutics
Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
PneumRx
PneumRx develops medical devices that assist in minimally invasive treatment of lung diseases.

Acquired by BTG Plc in 2014.
Precision NanoSystems
Precision NanoSystems develops innovative tools and processes to formulate and manufacture nanoparticles used as medicines and in medical research.
Rarecyte
RareCyte develops technologies focused on the detection of rare cellular events, beginning with circulating tumor cells.
SAGE Labs
A leading provider of novel research models and support services. SAGE specializes in genetic manipulation of in vivo systems for R&D applications.

Acquired by Horizon Discovery in 2014.
Specific Diagnostics
Specific Diagnostics utilizes unique sensor technology to enable rapid, cost effective, high throughput clinical microbiology diagnostic products, starting with the Reveal rapid susceptibility test platform.
SwitchGear
SwitchGear Genomics provides technologies and reagents for understanding gene regulation and function.

Acquired by Active Motif in 2013.
Teknova
Teknova manufactures and sells cell culture media and buffers into the research and bioproduction markets.
Trakcel
TrakCel offers a unique software platform that facilitates efficiency in cell and gene therapy by providing a solution to collate, track and document program-critical information.
Verogen
Verogen is a forensic science company leveraging next generation sequencing to serve the needs of law enforcement, criminal justice and national security organizations.
VidaCare
VidaCare’s platform provides rapid access to bone for applications that include emergency vascular access and bone marrow aspiration and biopsy.

Acquired by Teleflex in 2013.